IP Library Granted Patent US 10,413,361
Granted Patent B2
US 10,413,361 · App. 15/488,571 · Granted Sep 17, 2019

Device and method for skin treatment

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,413,361
App. No.
15/488,571
Granted
Sep 17, 2019
Kind
B2
Abstract

A device and a method for fractional skin treatment. The device employs two diffractive optical elements. One of the diffractive optical elements provides two coaxial laser beams and another diffractive optical element splits the two coaxial laser beams into a plurality of beamlets. A lens arranged to receive the plurality of the laser beams and to focus them in a skin treatment plane. The lens forms an image where each of the beamlets is imaged as a spot with a high intensity central area and a lower intensity area surrounding the central area.

Claims (15)

1. A device for treating biological tissue, comprising:

a laser configured to provide a laser beam;

a first diffractive optical element configured to receive the laser beam and transform distribution of energy in the laser beam to a central spot and a surrounding ring of energy;

a second diffractive optical element configured to receive the laser beam with transformed distribution of energy and to split it into at least two laser beams; and

a lens arranged to receive the at least two laser beams and to focus the at least two laser beams and in a skin treatment plane,

wherein a separation angle of the first diffractive optical element supports diameter of a ring-shaped beam of 0.2 mm to 0.5 mm; and

wherein a separation angle of the second diffractive optical element is designed to set inter-spot distance between beamlets of 0.2 mm to 1 mm.

2. The device of claim 1 , wherein the laser provides a single transversal mode (TEM 00 ) laser beam.

3. The device of claim 1 , wherein the first diffractive optical element is a diffractive axicon.

4. The device of claim 1 , wherein the first diffractive optical element transforms distribution of energy of incident laser beam into a ring-shaped laser beam and a central laser beam.

5. The device of claim 4 , wherein the ring-shaped laser beam and the central laser beam are coaxial beams.

6. The device of claim 4 , wherein a different ratio of laser intensity is coupled into the ring shaped laser beam and the central laser beam and wherein the ratio is a variable ratio.

7. The device for skin treatment of claim 4 , wherein a lens forms in an image plane an image of the ring-shaped beam surrounded by an image of a central laser beam.

8. The device of claim 1 , wherein centers of the image of a ring-shaped beam surrounded by an image of a central laser beam are located on a same grid points.

9. The device of claim 1 , wherein the second diffractive optical element is a diffractive beam splitter.

Assignments (5)
NOTICE OF SUCCESSION OF AGENCY AT REEL/FRAME 059593/0269 Recorded May 29, 2026
From: BARCLAYS BANK PLC, AS PRIOR COLLATERAL AGENT
To: HSBC BANK USA, N.A., AS SUCCESSOR COLLATERAL AGENT
Reel/Frame 075648/0952 →
RELEASE (REEL 043925 / FRAME 0001) Recorded Apr 4, 2022
From: ING CAPITAL LLC
To: SYNERON MEDICAL LTD.; CANDELA CORPORATION; PRIMAEVA CORPORATION
Reel/Frame 059593/0131 →
SECURITY AGREEMENT Recorded Apr 4, 2022
From: CANDELA CORPORATION; SYNERON MEDICAL LTD.
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 059593/0269 →
SECURITY AGREEMENT Recorded Sep 20, 2017
From: SYNERON MEDICAL LTD.; CANDELA CORPORATION; PRIMAEVA CORPORATION
To: ING CAPITAL LLC, AS COLLATERAL AGENT
Reel/Frame 043925/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 17, 2017
From: BHAWALKAR, JAYANT; SCHOMACKER, KEVIN
To: CANDELA CORPORATION
Reel/Frame 042025/0520 →